Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
NC Global Advantage Forum
Event | 11. 10. 2022
Karent LeVert will be speaking at the NC Global Advantage Forum on the impact of climate change on agriculture and how North Carolina's growing AgTech prowess can make a global impact.
